Immunocompetent Patients Cytomegalovirus Reactivation in Critically Ill

[1]  V. Krishnamurthi.  Meta-Analysis: The Efficacy of Strategies to Prevent Organ Disease by Cytomegalovirus in Solid Organ Transplant Recipients , 2006 .

[2]  D. Snydman,et al.  Preventing post-organ transplantation cytomegalovirus disease with ganciclovir: a meta-analysis comparing prophylactic and preemptive therapies. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[3]  Manfred Weiss,et al.  Active Cytomegalovirus Infection in Patients with Septic Shock , 2006, Emerging infectious diseases.

[4]  D. Sedmak,et al.  Lipopolysaccharide, Tumor Necrosis Factor Alpha, or Interleukin-1β Triggers Reactivation of Latent Cytomegalovirus in Immunocompetent Mice , 2006, Journal of Virology.

[5]  A. Limaye,et al.  Impact of Cytomegalovirus in Organ Transplant Recipients in the Era of Antiviral Prophylaxis , 2006, Transplantation.

[6]  M. Schumacher,et al.  Use of Multistate Models to Assess Prolongation of Intensive Care Unit Stay Due to Nosocomial Infection , 2006, Infection Control & Hospital Epidemiology.

[7]  D. Sedmak,et al.  Pulmonary cytomegalovirus reactivation causes pathology in immunocompetent mice* , 2006, Critical care medicine.

[8]  Sanjay Saint,et al.  Clinical and economic consequences of ventilator-associated pneumonia: A systematic review , 2005, Critical care medicine.

[9]  A. Webster,et al.  Antiviral medications to prevent cytomegalovirus disease and early death in recipients of solid-organ transplants: a systematic review of randomised controlled trials , 2005, The Lancet.

[10]  D. Snydman,et al.  The clinical impact of ganciclovir prophylaxis on the occurrence of bacteremia in orthotopic liver transplant recipients. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  H. Rollag,et al.  Impact of early cytomegalovirus infection and disease on long-term recipient and kidney graft survival. , 2004, Kidney international.

[12]  T. Stevens-Ayers,et al.  Optimization of Quantitative Detection of Cytomegalovirus DNA in Plasma by Real-Time PCR , 2004, Journal of Clinical Microbiology.

[13]  C. Cook,et al.  Occult herpes family viral infections are endemic in critically ill surgical patients , 2003, Critical care medicine.

[14]  R. Gaston,et al.  Determinants of Cardiovascular Mortality After Renal Transplantation: A Role For Cytomegalovirus? , 2003, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[15]  D. Sedmak,et al.  Intra-abdominal bacterial infection reactivates latent pulmonary cytomegalovirus in immunocompetent mice. , 2002, The Journal of infectious diseases.

[16]  G. Jahn,et al.  Human cytomegalovirus infections in nonimmunosuppressed critically ill patients , 2001, Critical care medicine.

[17]  T. Merigan,et al.  Impact of prophylactic immediate posttransplant ganciclovir on development of transplant atherosclerosis: a post hoc analysis of a randomized, placebo-controlled study. , 1999, Circulation.

[18]  J. Squifflet,et al.  Valacyclovir for the prevention of cytomegalovirus disease after renal transplantation. International Valacyclovir Cytomegalovirus Prophylaxis Transplantation Study Group. , 1999, The New England journal of medicine.

[19]  C. Cook,et al.  Occult herpes family viruses may increase mortality in critically ill surgical patients. , 1998, American journal of surgery.

[20]  H. Hackstein,et al.  High incidence of active cytomegalovirus infection among septic patients. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[21]  J. Torre-Cisneros,et al.  Posttransplant lymphoproliferative disease in primary Epstein-Barr virus infection after liver transplantation: the role of cytomegalovirus disease. , 1997, The Journal of infectious diseases.

[22]  D. Snydman,et al.  The independent role of cytomegalovirus as a risk factor for invasive fungal disease in orthotopic liver transplant recipients. Boston Center for Liver Transplantation CMVIG-Study Group. Cytogam, MedImmune, Inc. Gaithersburg, Maryland. , 1997, The American journal of medicine.

[23]  F. Basset,et al.  Evaluation of bronchoscopic techniques for the diagnosis of nosocomial pneumonia. , 1995, American journal of respiratory and critical care medicine.

[24]  Didier Pittet,et al.  Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality. , 1994, JAMA.

[25]  F. Harrell,et al.  Partial Proportional Odds Models for Ordinal Response Variables , 1990 .

[26]  J. Bale,et al.  The Epidemiology of Cytomegalovirus Infection Among Patients with Burns , 1990, Infection Control & Hospital Epidemiology.

[27]  J. Bale,et al.  Cytomegalovirus infection in burn patients. , 1987, The Journal of burn care & rehabilitation.

[28]  J. L. Gall,et al.  APACHE II--a severity of disease classification system. , 1986, Critical care medicine.

[29]  S. Zeger,et al.  Longitudinal data analysis using generalized linear models , 1986 .

[30]  W. Haddon,et al.  The injury severity score: a method for describing patients with multiple injuries and evaluating emergency care. , 1974, The Journal of trauma.

[31]  S. Jaber,et al.  Cytomegalovirus infection in critically ill patients: associated factors and consequences. , 2005, Chest.

[32]  P. McCullagh.  Regression Models for Ordinal Data , 1980 .